Half (50 percent) of a sample of health care industry C-suite executives surveyed last month expect the Biden administration to “formally obligate drug manufacturers to offer 340B pricing,” consulting firm Advis reports in its first health care industry leadership survey
…
USA Today, America’s top newspaper ranked by circulation, says claims circulating on social media that the Biden administration raised insulin prices by freezing a 340B-related Trump administration rule are “missing context.”
Last Friday, the national newspaper’s Fact Check feature
…
Forty-four New York state legislators have signed a letter to Gov. Andrew Cuomo (D) expressing “strong opposition” to the scheduled transfer in April of Medicaid managed care pharmacy benefits to Medicaid fee for service. They said the transfer “will have
…
Humorist Bill Maher, host of HBO’s long-running Real Time with Bill Maher program, on Friday “honored” former U.S. House Energy and Commerce Chair Henry Waxman (D-Calif.) with a new award for unheralded public service—the Baldy. Waxman was a driving force
…
Nearly all 340B-related program guidance documents have been taken down from an online database that the Trump administration launched last summer to underscore its position that federal government guidance documents are non-binding.
The U.S. Health Resources and Services Administration’s (HRSA)
…
The battle in the courts among providers, drug manufacturers, and health officials over 340B contract pharmacy likely will take time to play out, 340B Report Publisher and CEO Ted Slafsky writes in his latest column for Omnicell (a 340B Report
…
The American Hospital Association (AHA) asked the Biden administration this week to immediately withdraw the Trump administration’s “most favored nation” (MFN) drug pricing interim final rule, in part, because of the damage it will do to 340B hospitals and “critical
…The U.S. Health Resources and Services Administration (HRSA) is requiring Pharmaceutical Associates, Inc. (PAI), a South Carolina-based generic liquid drug manufacturer, to repay 340B covered entities for charges on its products above the 340B ceiling price discovered during a fiscal
…Illinois-based Eton Pharmaceuticals is making its Alkindi Sprinkle hydrocortisone product available through a sole specialty distributor “to ensure that patients…receive appropriate drug and clinical counseling and to support therapeutic adherence,” the company informed 340B covered entities in a Jan. 12
…*Sign up for news summaries and alerts from 340B Report